23 Jul - 2 min read

Dispensation Received on 60 Day Rule to Dispatch Circular

Dispensation Received on 60 Day Rule to Dispatch Circular

 Ascendis Health Limited
 (Registration number 2008/005856/06)
 (Incorporated in the Republic of South Africa)
 Share code: ASC
 ISIN: ZAE000185005
 (“Ascendis Health” or “the Company”)


                     DISPENSATION RECEIVED ON 60 DAY RULE TO DISPATCH CIRCULAR


Shareholders are referred to the announcement released on 26 May 2021 regarding the proposed disposal of
Respiratory Care Africa Proprietary Limited (“RCA”), the announcements dated 12 May 2021 and 9 July 2021 regarding
the proposed transaction for the recapitalisation of Ascendis Health (“the Group Recapitalisation Transaction”) and
the announcement dated 19 July 2021 regarding the proposed disposal of the Ascendis Animal Health division (“the
Animal Health Disposal”).

Shareholders are advised that the Company has, in relation to the proposed disposal of RCA (“the RCA Disposal”),
received dispensation from compliance with paragraph 9.20(b) of the JSE Limited Listings Requirements which
stipulates that a company must dispatch a circular to its shareholders containing a notice of general meeting to obtain
their approval for a transaction within 60 days of the date of announcement of such transaction. Shareholders are further
advised that a single circular containing details pertaining to the RCA Disposal, the Animal Health Disposal and the
Group Recapitalisation Transaction, as well as a notice of general meeting to obtain the approval of shareholders for all
three of these transactions, is expected to be dispatched on or about 31 August 2021.


23 July 2021
Bryanston

Sponsor
Questco Corporate Advisory Proprietary Limited

Date: 23-07-2021 08:48:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Ascendis Health Limited (JSE:ASC) when you join Listcorp.